Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Sinco Pharmaceuticals Holdings Ltd. ( (HK:6833) ).
Sinco Pharmaceuticals Holdings Ltd. successfully conducted its Annual General Meeting on May 15, 2025, where all proposed resolutions were unanimously approved by shareholders. Key resolutions included the adoption of the audited financial statements for 2024, re-election of directors, re-appointment of the auditor, and approval of a final dividend, reflecting strong shareholder support and stable governance.
More about Sinco Pharmaceuticals Holdings Ltd.
Sinco Pharmaceuticals Holdings Ltd. is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It focuses on the development and distribution of pharmaceutical products, catering to a diverse market with a range of healthcare solutions.
Average Trading Volume: 524,814
Technical Sentiment Signal: Sell
Current Market Cap: HK$382.2M
For a thorough assessment of 6833 stock, go to TipRanks’ Stock Analysis page.